137 related articles for article (PubMed ID: 25506890)
1. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
Yang P; Huo Z; Liao H; Zhou Q
Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
[TBL] [Abstract][Full Text] [Related]
2. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
Meng M; Guo Y; Chen Y; Li X; Zhang B; Xie Z; Liu J; Zhao Z; Liu Y; Zhang T; Qiao Y; Shang B; Zhou Q
Cell Oncol (Dordr); 2024 Apr; 47(2):657-676. PubMed ID: 37924456
[TBL] [Abstract][Full Text] [Related]
3. Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis.
Carter JA; Matta B; Battaglia J; Somerville C; Harris BD; LaPan M; Atwal GS; Barnes BJ
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38135347
[TBL] [Abstract][Full Text] [Related]
4. Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.
Hikmet F; Rassy M; Backman M; Méar L; Mattsson JSM; Djureinovic D; Botling J; Brunnström H; Micke P; Lindskog C
Mol Oncol; 2023 Dec; 17(12):2603-2617. PubMed ID: 37341056
[TBL] [Abstract][Full Text] [Related]
5. Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy.
Shim K; Jo H; Jeoung D
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834126
[TBL] [Abstract][Full Text] [Related]
6. A new high-throughput screening methodology for the discovery of cancer-testis antigen using multi-omics data.
Li D; Xia L; Zhang X; Liu Y; Wang Z; Guo Q; Huang P; Leng W; Qin S
Comput Methods Programs Biomed; 2024 Jun; 250():108193. PubMed ID: 38678957
[TBL] [Abstract][Full Text] [Related]
7. Profiling cancer testis antigens in non-small-cell lung cancer.
Djureinovic D; Hallström BM; Horie M; Mattsson JSM; La Fleur L; Fagerberg L; Brunnström H; Lindskog C; Madjar K; Rahnenführer J; Ekman S; Ståhle E; Koyi H; Brandén E; Edlund K; Hengstler JG; Lambe M; Saito A; Botling J; Pontén F; Uhlén M; Micke P
JCI Insight; 2016 Jul; 1(10):e86837. PubMed ID: 27699219
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer.
Vlasenkova R; Konysheva D; Nurgalieva A; Kiyamova R
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835834
[TBL] [Abstract][Full Text] [Related]
9. Cancer testis antigens and melanoma stem cells: new promises for therapeutic intervention.
Sigalotti L; Covre A; Nicolay HJ; Coral S; Maio M
Cancer Immunol Immunother; 2010 Mar; 59(3):487-8. PubMed ID: 19862522
[No Abstract] [Full Text] [Related]
10. The Cancer Testis Antigen Testis Specific Serine Kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors.
Delgado M; Gallegos Z; McGlynn K; Stippec S; Cobb MH; Whitehurst A
bioRxiv; 2024 Apr; ():. PubMed ID: 38260312
[TBL] [Abstract][Full Text] [Related]
11. Testis Specific Serine Kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors.
Delgado M; Gallegos Z; Stippec S; McGlynn K; Cobb MH; Whitehurst AW
J Biol Chem; 2024 May; ():107380. PubMed ID: 38762178
[TBL] [Abstract][Full Text] [Related]
12. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer.
Naik A; Lattab B; Qasem H; Decock J
Mol Ther Oncol; 2024 Mar; 32(1):200768. PubMed ID: 38596293
[TBL] [Abstract][Full Text] [Related]
13. Cancer/testis antigens and gametogenesis: a review and "brain-storming" session.
Kalejs M; Erenpreisa J
Cancer Cell Int; 2005 Feb; 5(1):4. PubMed ID: 15715909
[TBL] [Abstract][Full Text] [Related]
14. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
15. The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.
Maine EA; Westcott JM; Prechtl AM; Dang TT; Whitehurst AW; Pearson GW
Oncotarget; 2016 Mar; 7(12):14708-26. PubMed ID: 26895102
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic cancer/testis antigens: prime candidates for immunotherapy.
Gjerstorff MF; Andersen MH; Ditzel HJ
Oncotarget; 2015 Jun; 6(18):15772-87. PubMed ID: 26158218
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer.
Maxfield KE; Taus PJ; Corcoran K; Wooten J; Macion J; Zhou Y; Borromeo M; Kollipara RK; Yan J; Xie Y; Xie XJ; Whitehurst AW
Nat Commun; 2015 Nov; 6():8840. PubMed ID: 26567849
[TBL] [Abstract][Full Text] [Related]
18. A novel cohort of cancer-testis biomarker genes revealed through meta-analysis of clinical data sets.
Sammut SJ; Feichtinger J; Stuart N; Wakeman JA; Larcombe L; McFarlane RJ
Oncoscience; 2014; 1(5):349-359. PubMed ID: 25594029
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.
Zamunér FT; Karia BT; de Oliveira CZ; Santos CR; Carvalho AL; Vettore AL
Mol Cancer Ther; 2015 Mar; 14(3):828-34. PubMed ID: 25564441
[TBL] [Abstract][Full Text] [Related]
20. Radiation promotes malignant phenotypes through SRC in breast cancer cells.
Kim RK; Cui YH; Yoo KC; Kim IG; Lee M; Choi YH; Suh Y; Lee SJ
Cancer Sci; 2015 Jan; 106(1):78-85. PubMed ID: 25533622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
